Squarepoint’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-105,305
| Closed | -$3.36M | – | 2703 |
|
|
2022
Q2 | $3.36M | Buy |
105,305
+29,727
| +39% | +$950K | 0.02% | 552 |
|
|
2022
Q1 | $2.62M | Buy |
75,578
+32,148
| +74% | +$1.11M | 0.01% | 681 |
|
|
2021
Q4 | $1.27M | Sell |
43,430
-8,374
| -16% | -$245K | ﹤0.01% | 1093 |
|
|
2021
Q3 | $1.32M | Buy |
51,804
+38,472
| +289% | +$980K | ﹤0.01% | 952 |
|
|
2021
Q2 | $467K | Buy |
13,332
+1,102
| +9% | +$38.6K | ﹤0.01% | 1657 |
|
|
2021
Q1 | $498K | Sell |
12,230
-4,789
| -28% | -$195K | ﹤0.01% | 1532 |
|
|
2020
Q4 | $737K | Buy |
17,019
+10,772
| +172% | +$466K | 0.01% | 1242 |
|
|
2020
Q3 | $344K | Sell |
6,247
-40,344
| -87% | -$2.22M | ﹤0.01% | 1594 |
|
|
2020
Q2 | $2.94M | Buy |
46,591
+36,878
| +380% | +$2.33M | 0.05% | 502 |
|
|
2020
Q1 | $496K | Sell |
9,713
-8,982
| -48% | -$459K | 0.01% | 1045 |
|
|
2019
Q4 | $1.49M | Sell |
18,695
-43,051
| -70% | -$3.42M | 0.01% | 1054 |
|
|
2019
Q3 | $3M | Sell |
61,746
-3,637
| -6% | -$176K | 0.03% | 640 |
|
|
2019
Q2 | $3.44M | Buy |
65,383
+44,483
| +213% | +$2.34M | 0.03% | 563 |
|
|
2019
Q1 | $1.11M | Buy |
20,900
+5,760
| +38% | +$305K | 0.01% | 1057 |
|
|
2018
Q4 | $621K | Sell |
15,140
-11,860
| -44% | -$486K | 0.01% | 1131 |
|
|
2018
Q3 | $1.03M | Sell |
27,000
-2,800
| -9% | -$106K | 0.01% | 973 |
|
|
2018
Q2 | $1.35M | Buy |
29,800
+11,400
| +62% | +$515K | 0.02% | 773 |
|
|
2018
Q1 | $889K | Sell |
18,400
-23,494
| -56% | -$1.14M | 0.01% | 848 |
|
|
2017
Q4 | $1.65M | Buy |
+41,894
| New | +$1.65M | 0.03% | 620 |
|
|
2017
Q2 | – | Sell |
-37,606
| Closed | -$1.39M | – | 1886 |
|
|
2017
Q1 | $1.39M | Buy |
37,606
+7,276
| +24% | +$268K | 0.04% | 480 |
|
|
2016
Q4 | $438K | Buy |
+30,330
| New | +$438K | 0.02% | 914 |
|